The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease. Galyfos G, Chamzin A, Saliaris K, Theodorou P, et al. J Vasc Surg 2024;80:279-287.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Galyfos G, Chamzin A, Saliaris K, Theodorou P, et al. The effect of cilostazol on late outcomes after endovascular treatment for occlusive femoropopliteal disease. J Vasc Surg 2024;80:279-287.
PMID: 38215952